NO753773L - - Google Patents
Info
- Publication number
- NO753773L NO753773L NO753773A NO753773A NO753773L NO 753773 L NO753773 L NO 753773L NO 753773 A NO753773 A NO 753773A NO 753773 A NO753773 A NO 753773A NO 753773 L NO753773 L NO 753773L
- Authority
- NO
- Norway
- Prior art keywords
- iodine
- mixture
- detection
- stated
- indicator
- Prior art date
Links
- 239000000203 mixture Substances 0.000 claims description 58
- 150000001875 compounds Chemical class 0.000 claims description 41
- 238000001514 detection method Methods 0.000 claims description 40
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 38
- 229910052740 iodine Inorganic materials 0.000 claims description 38
- 239000011630 iodine Substances 0.000 claims description 38
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 claims description 34
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 claims description 34
- 229940116269 uric acid Drugs 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 27
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical group [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 18
- 239000000758 substrate Substances 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 17
- 238000006243 chemical reaction Methods 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 12
- 239000012528 membrane Substances 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 10
- 229940032147 starch Drugs 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 239000011888 foil Substances 0.000 claims description 8
- GUBGYTABKSRVRQ-ASMJPISFSA-N alpha-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 claims description 7
- -1 inert Substances 0.000 claims description 6
- 239000004800 polyvinyl chloride Substances 0.000 claims description 6
- 239000003365 glass fiber Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 5
- 239000000020 Nitrocellulose Substances 0.000 claims description 3
- 229910000288 alkali metal carbonate Inorganic materials 0.000 claims description 3
- 150000008041 alkali metal carbonates Chemical group 0.000 claims description 3
- 229920001220 nitrocellulos Polymers 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 229920000945 Amylopectin Polymers 0.000 claims description 2
- 229920000856 Amylose Polymers 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
- 229940068984 polyvinyl alcohol Drugs 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 229940079832 sodium starch glycolate Drugs 0.000 claims description 2
- 229920003109 sodium starch glycolate Polymers 0.000 claims description 2
- 239000008109 sodium starch glycolate Substances 0.000 claims description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 2
- 239000004744 fabric Substances 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 39
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000008859 change Effects 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 201000005569 Gout Diseases 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000011152 fibreglass Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- NUIURNJTPRWVAP-UHFFFAOYSA-N 3,3'-Dimethylbenzidine Chemical compound C1=C(N)C(C)=CC(C=2C=C(C)C(N)=CC=2)=C1 NUIURNJTPRWVAP-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 229920002160 Celluloid Polymers 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007705 chemical test Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 150000002843 nonmetals Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 125000004151 quinonyl group Chemical group 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- WRTMQOHKMFDUKX-UHFFFAOYSA-N triiodide Chemical compound I[I-]I WRTMQOHKMFDUKX-UHFFFAOYSA-N 0.000 description 1
- 229920011532 unplasticized polyvinyl chloride Polymers 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
- G01N33/523—Single-layer analytical elements the element being adapted for a specific analyte
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
- Y10T436/148888—Uric acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Examining Or Testing Airtightness (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4871574 | 1974-11-11 | ||
| GB48714/74A GB1527225A (en) | 1974-11-11 | 1974-11-11 | Testing device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO753773L true NO753773L (nl) | 1976-05-12 |
Family
ID=26266320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO753773A NO753773L (nl) | 1974-11-11 | 1975-11-11 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4234313A (nl) |
| JP (1) | JPS5171185A (nl) |
| AT (1) | AT347600B (nl) |
| AU (1) | AU510140B2 (nl) |
| BR (1) | BR7507419A (nl) |
| CA (1) | CA1086196A (nl) |
| CH (1) | CH618016A5 (nl) |
| CS (1) | CS207346B2 (nl) |
| DE (1) | DE2550634A1 (nl) |
| DK (1) | DK506775A (nl) |
| ES (1) | ES442507A1 (nl) |
| FI (1) | FI753157A (nl) |
| FR (1) | FR2290663A1 (nl) |
| GR (1) | GR57850B (nl) |
| HU (1) | HU176045B (nl) |
| IE (1) | IE42062B1 (nl) |
| IL (1) | IL48458A (nl) |
| IN (1) | IN144448B (nl) |
| IT (1) | IT1052184B (nl) |
| NL (1) | NL7513185A (nl) |
| NO (1) | NO753773L (nl) |
| PH (1) | PH14494A (nl) |
| SE (1) | SE7512632L (nl) |
| YU (1) | YU284975A (nl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51151190A (en) * | 1975-06-19 | 1976-12-25 | Sugiyama Sangyo Kagaku Kenkyusho | Testing paper for measurement of oil and fat peroxide value |
| NO770196L (no) * | 1976-01-22 | 1977-07-25 | Wellcome Found | Kjemiske pr¦vesystemer. |
| DE2744046A1 (de) * | 1977-09-30 | 1979-04-12 | Boehringer Mannheim Gmbh | Schnelldiagnosticum zur bestimmung von harnsaeure in koerperfluessigkeiten |
| US4387164A (en) * | 1980-11-05 | 1983-06-07 | Fmc Corporation | Method and apparatus for chemical analysis using reactive reagents dispersed in soluble film |
| CA1226792A (en) * | 1983-05-12 | 1987-09-15 | Steven C. Charlton | Ion test means having a hydrophilic carrier matrix |
| CA1222438A (en) * | 1983-05-12 | 1987-06-02 | Steven C. Charlton | Unified test means for ion determination |
| US4523852A (en) * | 1983-06-09 | 1985-06-18 | Miles Laboratories, Inc. | Color comparison reference standard and method for using same |
| CA1253057A (en) * | 1984-02-24 | 1989-04-25 | Mary L. Gantzer | Ion test means having a porous carrier matrix |
| US4855228A (en) * | 1987-09-11 | 1989-08-08 | Miles Inc. | Multiple oxidative indicator system for visual determination of hydrogen peroxide |
| US5071772A (en) * | 1988-02-08 | 1991-12-10 | Raffaele Beli | Device for carrying out extemporaneous quantitative diagnostic tests on whole blood |
| AU602277B2 (en) * | 1988-02-10 | 1990-10-04 | Miles Inc. | Self-indicating and improved resolution analyses employing stoichiometric chemical substraction |
| US5268054A (en) * | 1990-01-31 | 1993-12-07 | Bakhos Youssef G | Mounted micro-samples of powdered solids and method of preparing the same |
| GB9308411D0 (en) * | 1993-04-23 | 1993-06-09 | Celsis Ltd | Detection of biological material |
| US5603897A (en) * | 1994-06-30 | 1997-02-18 | Bausch & Lomb Incorporated | Method for indicating neutralization of contact lens disinfecting solutions |
| US6512857B1 (en) * | 1997-05-09 | 2003-01-28 | Sarnoff Corporation | Method and apparatus for performing geo-spatial registration |
| US6699720B1 (en) * | 2000-05-26 | 2004-03-02 | Development Center For Biotechnology | Interference-eliminating membranes, test strips, kits and methods for use in uric acid assay |
| EP2014224A1 (en) * | 2006-03-24 | 2009-01-14 | GlucoTel Scientific Inc. | Telemedical method and device for the calibration of measured values |
| US10082495B2 (en) | 2016-03-18 | 2018-09-25 | Vision Diagnostics, Inc. | Methods for the detection of oxidative adulterants in urine sample |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL289920A (nl) * | 1951-01-28 | |||
| US2785057A (en) * | 1953-12-08 | 1957-03-12 | Union Central Life Insurance C | Device for testing liquids |
| US3485587A (en) * | 1956-02-29 | 1969-12-23 | Miles Lab | Protein indicator |
| US2986453A (en) * | 1957-11-13 | 1961-05-30 | Miles Lab | Diagnostic compositions |
| US2996436A (en) * | 1958-06-02 | 1961-08-15 | Sigma Chem Co | Process for the colorimetric determination of lactic dehydrogenase |
| US3139328A (en) * | 1960-07-21 | 1964-06-30 | Sun Oil Co | Indicator paper |
| NL134608C (nl) * | 1963-06-17 | |||
| NL129843C (nl) * | 1965-05-20 | |||
| US3552928A (en) * | 1967-07-19 | 1971-01-05 | Miles Lab | Whole blood separation means and test system using same |
| US3536448A (en) * | 1967-07-28 | 1970-10-27 | Miles Lab | Uric acid detection |
| US3511608A (en) * | 1967-12-14 | 1970-05-12 | Harold P Anderson | Multiple layer paper test strip |
| US3607093A (en) * | 1968-02-15 | 1971-09-21 | Schering Corp | Devices for testing biological liquids |
| US3528777A (en) * | 1968-09-27 | 1970-09-15 | Hycel Inc | Process and compositions for determination of uric acid in blood serum |
| US3649198A (en) * | 1970-05-19 | 1972-03-14 | Pfizer & Co C | Diagnostic method for the determination of uric acid in blood |
| GB1282089A (en) * | 1970-10-28 | 1972-07-19 | Miles Lab | Composition for the detection of uric acid |
| US3798004A (en) * | 1972-04-18 | 1974-03-19 | Ames Yissum Ltd | Test device |
| US3822115A (en) * | 1972-08-30 | 1974-07-02 | Medico Electronic Inc | Method and reagent for uric acid determination |
| US3846247A (en) * | 1972-09-27 | 1974-11-05 | Warner Lambert Co | Moisture barrier |
| US4141688A (en) * | 1977-08-11 | 1979-02-27 | Miles Laboratories, Inc. | Composition, device and method for determining reducing agents |
-
1975
- 1975-11-07 AT AT848475A patent/AT347600B/de not_active IP Right Cessation
- 1975-11-10 CA CA239,607A patent/CA1086196A/en not_active Expired
- 1975-11-10 FR FR7534270A patent/FR2290663A1/fr active Granted
- 1975-11-11 CH CH1457875A patent/CH618016A5/de not_active IP Right Cessation
- 1975-11-11 ES ES442507A patent/ES442507A1/es not_active Expired
- 1975-11-11 FI FI753157A patent/FI753157A/fi not_active Application Discontinuation
- 1975-11-11 DK DK506775A patent/DK506775A/da unknown
- 1975-11-11 GR GR49345A patent/GR57850B/el unknown
- 1975-11-11 AU AU86498/75A patent/AU510140B2/en not_active Expired
- 1975-11-11 DE DE19752550634 patent/DE2550634A1/de not_active Withdrawn
- 1975-11-11 YU YU02849/75A patent/YU284975A/xx unknown
- 1975-11-11 IT IT52168/75A patent/IT1052184B/it active
- 1975-11-11 NL NL7513185A patent/NL7513185A/nl not_active Application Discontinuation
- 1975-11-11 IE IE2456/75A patent/IE42062B1/en unknown
- 1975-11-11 SE SE7512632A patent/SE7512632L/ unknown
- 1975-11-11 PH PH17760A patent/PH14494A/en unknown
- 1975-11-11 NO NO753773A patent/NO753773L/no unknown
- 1975-11-11 BR BR7507419*A patent/BR7507419A/pt unknown
- 1975-11-11 IL IL48458A patent/IL48458A/xx unknown
- 1975-11-11 JP JP50135579A patent/JPS5171185A/ja active Pending
- 1975-11-11 CS CS757593A patent/CS207346B2/cs unknown
- 1975-11-11 HU HU75WE529A patent/HU176045B/hu unknown
-
1976
- 1976-05-07 IN IN797/CAL/76A patent/IN144448B/en unknown
-
1978
- 1978-06-05 US US05/912,349 patent/US4234313A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| BR7507419A (pt) | 1976-08-03 |
| JPS5171185A (nl) | 1976-06-19 |
| AU8649875A (en) | 1977-05-19 |
| HU176045B (en) | 1980-11-28 |
| AU510140B2 (en) | 1980-06-12 |
| IN144448B (nl) | 1978-05-06 |
| FI753157A (nl) | 1976-05-12 |
| ES442507A1 (es) | 1977-08-16 |
| YU284975A (en) | 1982-06-30 |
| CA1086196A (en) | 1980-09-23 |
| IE42062L (en) | 1976-05-11 |
| CH618016A5 (nl) | 1980-06-30 |
| GR57850B (en) | 1977-07-04 |
| ATA848475A (de) | 1978-05-15 |
| DE2550634A1 (de) | 1976-05-13 |
| DK506775A (da) | 1976-05-12 |
| FR2290663B1 (nl) | 1981-09-18 |
| PH14494A (en) | 1981-08-14 |
| IL48458A0 (en) | 1976-01-30 |
| CS207346B2 (en) | 1981-07-31 |
| IE42062B1 (en) | 1980-05-21 |
| IL48458A (en) | 1979-03-12 |
| FR2290663A1 (fr) | 1976-06-04 |
| IT1052184B (it) | 1981-06-20 |
| NL7513185A (nl) | 1976-05-13 |
| SE7512632L (sv) | 1976-05-12 |
| US4234313A (en) | 1980-11-18 |
| AT347600B (de) | 1979-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO753773L (nl) | ||
| EP0020788B1 (en) | Test piece for measuring glucose | |
| US3092465A (en) | Diagnostic test device for blood sugar | |
| US3298789A (en) | Test article for the detection of glucose | |
| CA2457665C (en) | Method for reducing effect of hematocrit on measurement of an analyte in whole blood, and test kit and test article useful in the method | |
| TW514727B (en) | Diagnostic test carrier with multi-layer test field | |
| US4211845A (en) | Glucose indicator and method | |
| EP0345781B1 (en) | Defined volume test device | |
| US4273868A (en) | Color stable glucose test | |
| NO130520B (nl) | ||
| US5888758A (en) | Broad range total available chlorine test strip | |
| JPS596900A (ja) | 高グルコース測定用分析素子及びその製造方法並びにそれを用いた測定方法 | |
| US5811254A (en) | Broad range total available chlorine test strip | |
| JPS61122568A (ja) | 水性試験試料中に含まれる高濃度領域のグルコースを半定量的に測定するための試験組成物、試験具および試験具の作製方法 | |
| FI80343C (fi) | Testanordning. | |
| US7067320B2 (en) | Sensor for luminescense-optical determination of an analyte | |
| US5976823A (en) | Low range total available chlorine test strip | |
| US5217691A (en) | Nonenzymatic glucose test | |
| EP0036563B1 (en) | Bilirubin-resistant composition for the determination of cholesterol, test device containing the composition and method of making the test device | |
| EP0041175B1 (en) | Ion specific analytical element | |
| US5116763A (en) | Nonenzymatic glucose test | |
| KR100458978B1 (ko) | 헤마토크릿에대한감도가낮은혈액글루코즈스트립 | |
| JPS6259782B2 (nl) | ||
| WO1998000703A1 (en) | Test strip including integral specimen flow retarding structure | |
| CA1254115A (en) | Nonenzymatic glucose test |